SynthesisFrontiers in endocrinology2025
The impact of mobile health interventions on maternal-neonatal outcomes in women with gestational diabetes mellitus: a systematic review and meta-analysis.
Synthesis in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Usability Evaluation of a Serious Game for Dietary Health Education in Gestational Diabetes Mellitus: A Mixed-Methods Study Based on the SGDA Framework.Journal of multidisciplinary healthcare · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gestational diabetes mellitus (GDM), a prevalent complication during pregnancy, is closely associated with an elevated risk of adverse maternal and neonatal outcomes. Mobile health (mHealth) technologies have emerged as convenient tools for GDM management; however, their clinical efficacy in improving maternal and neonatal outcomes among GDM-affected pregnant individuals remains to be comprehensively evaluated. Objective: The study aims to evaluate the effectiveness of mHealth interventions in improving maternal and neonatal outcomes among pregnant individuals with GDM. Methods: This study systematically searched the PubMed, Web of Science, Scopus, Cochrane Library, and EMBASE databases from their inception to July 23, 2025. Two researchers independently screened the studies, extracted data, and assessed quality. All data analyses were performed using STATA 17.0 software. Results: Compared with routine care, mHealth interventions significantly reduced the risk of cesarean section (OR 0.76, 95% CI 0.63-0.91) and emergency cesarean (OR 0.55, 95% CI 0.39-0.77) among women with GDM. Additionally, a significant reduction in the risk of composite neonatal complications was observed (OR 0.63, 95% CI 0.44-0.89). Furthermore, mHealth interventions significantly improved 2-hour postprandial blood glucose levels (SMD -0.36, 95% CI -0.53 to -0.19). A trend toward reduced gestational weight gain was also noted in the mHealth intervention group (SMD -0.37, 95% CI -0.83 to 0.08). Conclusion: mHealth interventions can reduce the risk of cesarean section rate and emergency cesarean section, as well as the risk of composite neonatal complications. mHealth interventions may also improve two-hour postprandial blood glucose control in pregnant women with GDM and can effectively supplement conventional clinical care for GDM. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420251149505.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.